Significance of pharmacist intervention to oral antithrombotic therapy in the pharmaceutical outpatient clinic of cardiovascular internal medicine: a retrospective cohort study

Table 2 Comparison of event incidences in the pharmacist intervention and non-intervention groups

	Intervention group (n = 132)	Non-intervention group (n = 264)	P-values
BARC bleeding greater than type 2	23 (17.4%)	75 (28.4%)	0.019
Death	18 (13.6%)	24 (9.0%)	0.17
Stroke events	4 (3.0%)	13 (4.9%)	0.44
Cardiovascular events^a	5 (3.8%)	24 (9.1%)	0.066
Hospitalizations due to heart failure	20 (15.1%)	39 (14.8%)	1.00

^aCardiovascular events are defined as undergoing PCI or CABG for myocardial infarction or unstable angina

ISSN: 2055-0294